These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 27472325)

  • 1. One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling.
    Corbin JM; Ruiz-Echevarría MJ
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27472325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen action in the prostate gland.
    Yadav N; Heemers HV
    Minerva Urol Nefrol; 2012 Mar; 64(1):35-49. PubMed ID: 22402316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.
    Audet-Walsh É; Dufour CR; Yee T; Zouanat FZ; Yan M; Kalloghlian G; Vernier M; Caron M; Bourque G; Scarlata E; Hamel L; Brimo F; Aprikian AG; Lapointe J; Chevalier S; Giguère V
    Genes Dev; 2017 Jun; 31(12):1228-1242. PubMed ID: 28724614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression.
    Nyquist MD; Dehm SM
    Horm Cancer; 2013 Apr; 4(2):61-9. PubMed ID: 23307762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism.
    Poluri RTK; Paquette V; Allain ÉP; Lafront C; Joly-Beauparlant C; Weidmann C; Droit A; Guillemette C; Pelletier M; Audet-Walsh É
    Endocr Relat Cancer; 2021 Apr; 28(4):257-271. PubMed ID: 33690159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independence of HIF1a and androgen signaling pathways in prostate cancer.
    Tran MGB; Bibby BAS; Yang L; Lo F; Warren AY; Shukla D; Osborne M; Hadfield J; Carroll T; Stark R; Scott H; Ramos-Montoya A; Massie C; Maxwell P; West CML; Mills IG; Neal DE
    BMC Cancer; 2020 May; 20(1):469. PubMed ID: 32450824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer.
    Zhao Y; Tindall DJ; Huang H
    Int J Biol Sci; 2014; 10(6):614-9. PubMed ID: 24948874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgens and androgen receptor signaling in prostate tumorigenesis.
    Zhou Y; Bolton EC; Jones JO
    J Mol Endocrinol; 2015 Feb; 54(1):R15-29. PubMed ID: 25351819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen action and metabolism in prostate cancer.
    Green SM; Mostaghel EA; Nelson PS
    Mol Cell Endocrinol; 2012 Sep; 360(1-2):3-13. PubMed ID: 22453214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells.
    Liu XH; Kirschenbaum A; Yao S; Liu G; Aaronson SA; Levine AC
    Cancer Res; 2007 Jun; 67(12):5747-53. PubMed ID: 17575141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails.
    Niu Y; Chang TM; Yeh S; Ma WL; Wang YZ; Chang C
    Oncogene; 2010 Jun; 29(25):3593-604. PubMed ID: 20440270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
    White MA; Tsouko E; Lin C; Rajapakshe K; Spencer JM; Wilkenfeld SR; Vakili SS; Pulliam TL; Awad D; Nikolos F; Katreddy RR; Kaipparettu BA; Sreekumar A; Zhang X; Cheung E; Coarfa C; Frigo DE
    Endocr Relat Cancer; 2018 Apr; 25(4):453-469. PubMed ID: 29431615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen Receptor Dependence.
    Chaturvedi AP; Dehm SM
    Adv Exp Med Biol; 2019; 1210():333-350. PubMed ID: 31900916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique targeting of androgen-dependent and -independent AR signaling in prostate cancer to overcome androgen resistance.
    Lim SC; Jansson PJ; Assinder SJ; Maleki S; Richardson DR; Kovacevic Z
    FASEB J; 2020 Sep; 34(9):11511-11528. PubMed ID: 32713076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor signaling in androgen-refractory prostate cancer.
    Grossmann ME; Huang H; Tindall DJ
    J Natl Cancer Inst; 2001 Nov; 93(22):1687-97. PubMed ID: 11717329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer.
    Singh VK; Kainat KM; Sharma PK
    Vitam Horm; 2023; 122():253-282. PubMed ID: 36863797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen action during prostate carcinogenesis.
    Wang D; Tindall DJ
    Methods Mol Biol; 2011; 776():25-44. PubMed ID: 21796518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.
    Correa RG; Krajewska M; Ware CF; Gerlic M; Reed JC
    Oncotarget; 2014 Mar; 5(6):1666-82. PubMed ID: 24681825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.